Skip to main content

Table 1 Incidence of autoantibodies to p53 compared with disease status at last clinic attendance

From: P53 autoantibodies in 1006 patients followed up for breast cancer

Disease status % Anti-p53 positive
Primary remission 14.7% (82/557)
Secondary remission 17.4% (27/155)
Secondary recurrent 19.4% (20/103)
Continuous active 16.5% (24/145)
Total 15.9% (153/96)*
  1. Pearson χ2: P = 0.606. *Information on disease status at last sample time was available for 960 out of 1006 patients